Abilify MyCite
These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002
e8787c3f-5e41-42d1-8091-44b56346620f
HUMAN PRESCRIPTION DRUG LABEL
Oct 16, 2023
Otsuka America Pharmaceutical, Inc.
DUNS: 008314390
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ARIPIPRAZOLE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
ARIPIPRAZOLE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
ARIPIPRAZOLE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
ARIPIPRAZOLE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
ARIPIPRAZOLE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
ARIPIPRAZOLE
Product Details
FDA regulatory identification and product classification information